$NSPR
InspireMD, Inc.
CIK:0001433607|SEC Filings
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Income Statement [Abstract] | ||||
| REVENUES | $ 1,771 | $ 1,778 | $ 5,169 | $ 3,307 |
| COST OF REVENUES | 2,545 | 1,465 | 5,256 | 2,702 |
| GROSS PROFIT (LOSS) | (774) | 313 | (87) | 605 |
| OPERATING EXPENSES: | ||||
| Research and development | 4,295 | 3,834 | 9,058 | 7,893 |
| Selling and marketing | 5,221 | 4,172 | 10,401 | 6,922 |
| General and administrative | 4,155 | 5,326 | 8,877 | 10,269 |
| Total operating expenses | 13,671 | 13,332 | 28,336 | 25,084 |
| LOSS FROM OPERATIONS | (14,445) | (13,019) | (28,423) | (24,479) |
| FINANCIAL INCOME (EXPENSE), net: | 121 | (132) | 410 | 162 |
| NET LOSS | $ (14,324) | $ (13,151) | $ (28,013) | $ (24,317) |
| NET LOSS PER SHARE - basic | $ (0.17) | $ (0.26) | $ (0.33) | $ (0.48) |
| NET LOSS PER SHARE - diluted | $ (0.17) | $ (0.26) | $ (0.33) | $ (0.48) |
| WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic | 84,659,943 | 51,003,900 | 84,236,742 | 50,508,660 |
| WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - diluted | 84,659,943 | 51,003,900 | 84,236,742 | 50,508,660 |